Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.5B | 5.1B | 5.1B |
Cost of revenue | 2.7B | 2.9B | 2.6B | 2.8B |
Gross profit | 2.3B | 2.5B | 2.5B | 2.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 1.4B | 1.4B | 1.2B |
Non operating interest income | ||||
Income | 2M | 2M | 1M | 0 |
Expense | 538M | 525M | 531M | 536M |
Other income expense | -131M | -77M | -89M | -91M |
Pretax income | 380M | 716M | 727M | 528M |
Tax provision | 100M | 158M | 201M | 134M |
Net income | 280M | 558M | 526M | 394M |
Basic EPS | 0.5 | 1.0 | 1.0 | 0.7 |
Diluted EPS | 0.5 | 1.0 | 1.0 | 0.7 |
Basic average shares | 538M | 536.5M | 534M | 533M |
Diluted average shares | 539M | 547.1M | 536M | 534M |
EBITDA | 2.2B | 2.5B | 2.5B | 2.3B |
Net income from continuing op. | 280M | 558M | 526M | 394M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |